Objective: To study the therapeutic effects and safety of patent technology ozone laser combined with puncture needle in the treatment of cervical spondylosis. Methods: 58 patients with cervical spondylosis received the treatment of patent technology ozone laser combined with puncture needle (hereafter referred to as combined needle) in our department from August 2008 to February 2010. VAS score changes before and 6 months after surgery and MacNab score criteria 6 months after surgery were analyzed. Results: After 6 to 9 months' follow-up, the VAS score of preoperative neck and shoulder pain was (6.57±1.34) scores. The VAS score of 1-week postoperative neck and shoulder pain was (1.80±0.65) scores and those of 1, 3 and 6 months were all 0 (0-2) scores. The VAS score of postoperative neck and shoulder pain obviously reduced compared with that of preoperative (H= 1.680, P=0.000), and the VAS scores of postoperative neck and shoulder pain in 6 months showed no significant rebound. 6-month follow-up showed that 29 patients were excellent, 23 good and 6 fair, with the excellent and good rate of 89.6% (52/58). Conclusion: Ozone laser combined with puncture needle for the treatment of cervical spondylosis is safe and effective.%目的:研究专利技术臭氧激光联合穿刺针治疗颈椎病的疗效和安全性.方法:对我科2008年8月～2010年2月收治的58例颈椎病患者,应用专利技术臭氧激光联合穿刺针(以下简称联合针)进行臭氧激光联合治疗,分析术前及术后6个月内VAS评分的变化及术后6个月MacNab评分标准.结果:随访6～9个月,术前颈肩痛VAS评分为(6.57±1.34)分,术后1周VAS评分(1.80±0.65)分,术后颈肩痛VAS评分较术前有明显降低(H=61.680,P=0.000),术后1、3、6个月VAS评分均为0(0～2)分,术后6个月内颈肩痛VAS评分无明显反弹.6个月随访时29例优,23例良,6例可,优良率为89.6%(52/58).结论:激光臭氧联合穿刺针介入治疗颈椎病安全且疗效显著.
展开▼
